Background Despite omega-3 polyunsaturated fatty acids (PUFA) supplementation in
depressed patients have been suggested to improve depressive symptomatology, previous …

Background In recent years, we have accomplished a deeper understanding about the
pathophysiology of major depressive disorder (MDD). Nevertheless, this improved …

Personalized medicine is rapidly becoming a reality in today's physical medicine. However,
as yet this is largely an aspirational goal in psychiatry, despite significant advances in our …

Emerging evidence relates some nutritional factors to depression risk. However, there is a
scarcity of longitudinal assessments on this relationship. Objective To evaluate the …

Psychiatric disorders like mood disorders, schizophrenia, or drug addiction affect a sizeable
proportion of the human population and severely compromise quality of life. Therefore …

Background Major depressive disorder is among main worldwide causes of disability. The
low medication compliance rates in depressed patients as well as the high recurrence rate …

Nervonic acid (NA) has attracted considerable attention because of its close relationship
with brain development. Sources of NA include oil crop seeds, oil-producing microalgae …

Background Depression is a common disorder affecting 10–15% women in the postpartum
period. Postpartum depression can disrupt early mother-infant interaction, and constitutes a …

Objective Cardiovascular disease (CVD) is the leading cause of death in severe psychiatric
disorders (depression, schizophrenia). Here, we provide evidence of how the effects of …

The use of biomarkers to predict who will develop schizophrenia (or other psychoses) is a
key theme in current psychiatric research that has important implications for the …